UroMems’ €16 Million Financing Round

Goodwin Procter LLP advised UroMems in the operation.

Medical device startup UroMems has raised €16 million in a round led by Hil-Invent. The company is developing an electronic artificial urinary sphincter to treat stress incontinence. The capital will be used to fund clinical trials.

This financing was completed with the participation of existing investors (Wellington Partners, Bpifrance, Cita Investissement, Supernova Invest and b-to-v Partners AG) as well as new investors, Hil-Invent Gmbh and Financière Arbevel. The capital will be used to fund clinical trials.

The Goodwin team was led by partner, Thomas Dupont-Sentilles (Picture) and included Yoann Labbé.

Involved fees earner: Thomas Dupont-Sentilles – Goodwin Procter; Yoann Labbé – Goodwin Procter;

Law Firms: Goodwin Procter;

Clients: UroMems SAS;